Kenvue Inc. has issued a report regarding the potential health impacts of acetaminophen use during pregnancy. The filing highlights findings suggesting a possible link between the use of the medication, commonly known as Tylenol, and anatomical changes in the reproductive organs of female offspring.
The report indicates that exposure to acetaminophen in utero may be associated with alterations in the uterus and ovaries of daughters. These observations were detailed in a news article published on September 8, 2026.
The filing serves as a disclosure of the reported research findings rather than a clinical trial result or a definitive medical conclusion. The text notes that the reported connection is a subject of ongoing scientific inquiry.
